(Q48819023)

15 February 2018

title

GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity. (English)

1 reference

15 February 2018

8

Coy DH

1 reference

15 February 2018

author name string

Ito T

1

1 reference

15 February 2018

Igarashi H

2

1 reference

15 February 2018

Pradhan TK

3

1 reference

15 February 2018

Hou W

4

1 reference

15 February 2018

Mantey SA

5

1 reference

15 February 2018

Taylor JE

6

1 reference

15 February 2018

Murphy WA

7

1 reference

15 February 2018

Jensen RT

9

1 reference

15 February 2018

publication date

1 July 2001

1 reference

15 February 2018

published in

Peptides

1 reference

15 February 2018

volume

22

1 reference

15 February 2018

issue

7

1 reference

15 February 2018

page(s)

1139-1151

1 reference

15 February 2018

Isolation and characterization of the porcine hypothalamic growth hormone releasing factor.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Human growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Structural simplification of potent growth hormone-releasing hormone analogs: implications for other members of the VIP/GHRH/PACAP family.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Strategies in the design of synthetic agonists and antagonists of growth hormone releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Antagonistic analogs of growth hormone releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Isolation and characterization of the bovine hypothalamic growth hormone releasing factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Interaction of secretin5–27 and its analogues with hormone receptors on pancreatic acini

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Stable expression of the recombinant human VIP1 receptor in clonal Chinese hamster ovary cells: pharmacological, functional and molecular properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Recombinant growth hormone therapy in patients with ischemic cardiomyopathy : effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Development of high affinity selective VIP1 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Super-active analogs of growth hormone-releasing factor (1-29)-amide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Potential applications of GH secretagogs in the evaluation and treatment of the age-related decline in growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Clinical diagnoses of children with extremely short stature and their response to growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Structure and function of the growth-hormone-releasing hormone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Comparative structural requirements of thirty GRF analogs for interaction with GRF- and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Growth hormone therapy for heart failure: swimming against the stream

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Solid phase synthesis of peptides containing the CH2NH peptide bond isostere

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Hormonal therapy for short bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

A preliminary study of growth hormone therapy for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Elements in the pathophysiology of diminished growth hormone (GH) secretion in aging humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Rhesus monkey gastroenteropancreatic hormones: relationship to human sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

Receptors for vasoactive intestinal peptide and secretin on guinea pig pancreatic acini

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900436-3

7 January 2021

10.1016/S0196-9781(01)00436-3

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018